Skip to main content
. 2020 Aug 22;7(3):514–520. doi: 10.5455/javar.2020.g448

Figure 2. Immunoreactivity of IL-6 in the testicular tissue of the testicular dysfunction rat treated with secretome. Immunoreactivities of IL-6 can be detected in the Leydig cells (red arrow), spermatogenic cells (black arrow), and luminal tissues (blue arrow). Figure 2A shows IHC staining of testicular dysfunction rat; 2B 1week after the first secretome treatment with 0.2 ml/kg BW; 2C 1 week after the second secretome treatment at the dosage of 0.2 ml/kg BW; 2D 1 week after the third secretome treatment with 0.2 ml/kg BW; 1 week after the second secretome treatment with 0.2 ml/kg BW; 2E 1 week after the first secretome treatment with 0.5 ml/kg BW; 2F 1 week after the second secretome treatment with 0.5 ml/kg BW; 2G 1 week after the third secretome treatment with the dosage of 0.5 ml/kg BW; 2H 1 week after the fourth secretome treatment with 0.5 ml/kg BW.

Figure 2.